According to a recent market study published by Growth Market Reports, titled, “Global Zolpidem Tartrate Market By Dosage Form/Strength, By Age Group, By Sales Channel, and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 733.0 Million in 2022 and is anticipated to grow at a growth rate of 3.2% by the year 2031.

Get Sample Report @ https://growthmarketreports.com/request-sample/6107

Zolpidem Tartrate is a sedative-hypnotic medication that is used to treat insomnia. It is a non-benzodiazepine receptor modulator primarily used in the FDA-approved short-term treatment of insomnia aimed at patients with difficulty starting sleep. Zolpidem Tartrate works by enhancing the activity of the neurotransmitter GABA in the brain, which results in reduced anxiety, relaxation, and drowsiness It belongs to the control substance class C IV medicines and is regulated by the drug Enforcement Agency.

It improves measures of sleep latency and sleep duration and reduces the number of awakenings in patients with transient insomnia. Zolpidem is rapidly absorbed by the gastrointestinal tract and has a short half-life in healthy patients. However, it is important to follow the prescribed dosage and not to take it unless directed by a doctor, as misuse can lead to dependence, withdrawal symptoms, and other adverse effects.

The global zolpidem tartrate market has been segmented in terms of by dosage form/strength, by age group, by sales channel, and region. In terms of dosage form/strength, the global zolpidem tartrate market is divided into tablet and oral spray. Based on the age group, the market is segmented into adult (15 to 64 Years) and geriatric (> age 65 Years). On the basis of the sales channel, the market is fragmented into online pharmacy, retail pharmacy, and hospital pharmacy. As regions, the market is separated into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The Coronavirus disease 2019 (COVID-19) pandemic highlighted monetary differences, global interdependence, and governance challenges. The global zolpidem tartrate market was positively impacted by the covid-19 due to rising cases of corona all over the world, and the growing adoption of insomnia in the hospital and clinics to improve immunity and boost energy. Market players are focusing on new products that are expected to drive the zolpidem tartrate market over the forecast period.

The influx of COVID-19 patients has put pressure on healthcare facilities, resulting in a rising demand for sleep disorders therapy. However, it is evident that the pharmaceutical industry, including the production and distribution of zolpidem tartrate, was affected by the COVID-19 pandemic. There were several challenges in the supply chain, such as disruptions in the manufacture of certain raw materials, transportation delays, reduced production capacities, and increased demand for certain medications. These factors may have impacted the availability and pricing of zolpidem tartrate in certain regions, but the extent of the impact remains uncertain.

As per growth market reports by industry Senior Associate “Anuradha More”, “The rise in geriatric population and stressful lifestyle habits are driving the demand for insomnia treatments, including zolpidem tartrate. Moreover, the growing awareness about the benefits of zolpidem tartrate and technological advancements in drug formulations will further fuel the market growth.

Key Takeaways from the Study:

  • The players in the global zolpidem tartrate market include Astellas Pharma US, Inc.; Consern Pharma Limited; Merit Pharmaceutical; Neuracle Lifesciences Private Limited; Par Pharmaceutical; Sanofi; Taj Pharmaceuticals Limited; Teva Pharmaceuticals USA, Inc.; and Others. These companies hold a portion of the global zolpidem tartrate market in 2022.

  • The global zolpidem tartrate market is primarily driven by factors such as increasing prevalence of insomnia, sleep disorders, and other related disorders, rise in the geriatric population, and stressful lifestyle habits. Additionally, growing awareness about the benefits of zolpidem tartrate and improvements and technological advancements in drug formulations are also driving the market growth.

  • Furthermore, the global zolpidem tartrate market is primarily driven by factors such as increasing prevalence of insomnia, sleep disorders, and other related disorders, rise in the geriatric population, and stressful lifestyle habits. Additionally, growing awareness about the benefits of zolpidem tartrate and improvements and technological advancements in drug formulations are also driving the market growth.

  • Based on dosage form/strength, the market is segmented into tablet and oral spray. In 2022, the tablet segment held the largest market share and is expected to grow with a 3.0% CAGR over the forecast period, due to it supports the immune system and prevents illness.

  • In terms of regions, the global zolpidem tartrate markets are divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America had a XX% share of the market in the year 2022, owing to established healthcare infrastructure, and rising incidences of insomnia, sleep disorders, and other related disorders, growing awareness of zolpidem tartrate, which is anticipated to boost the market in the coming years.

Scope of the Zolpidem Tartrate Market Report:

Report Metric

Details

Market Value in 2022

US$ 733.0 Million

Market Growth Rate (from 2023 to 2031)

3.2%

Historical Data

2016 & 2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By Dosage Form/Strength, By Age Group, By Sales Channel, and By Region

Key Companies Profiled

Astellas Pharma US, Inc.; Consern Pharma Limited; Merit Pharmaceutical; Neuracle Lifesciences Private Limited; Par Pharmaceutical; Sanofi; Taj Pharmaceuticals Limited; Teva Pharmaceuticals USA, Inc.; and Others

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

Target Audience:

  • Supply-side: Vendor, Manufacturer, Distributors, Supplier.

  • Demand Side: Healthcare, Pharmaceuticals, and Others.

  • Regulatory Side: Concerned government authorities, and other approved regulatory bodies.

  • Associations and Industry Bodies: World Health Organization (WHO), Food Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), National Health Expenditure (NIH) etc.